Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Anktiva (nogapendekin alfa inbakicept-pmln)
i
Other names:
ALT-803, IL-15N72D:IL-15RαSu/Fc fusion protein complex, ALT 803, N-803, IL-15N72D:IL-15RαSu/IgG1 Fc complex
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
ImmunityBio
Drug class:
IL-15 superagonist
Related drugs:
‹
SOT101 (0)
SOT101 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Bladder Cancer
No biomarker
Bladder Cancer
nogapendekin alfa inbakicept-pmln
Sensitive: B - Late Trials
nogapendekin alfa inbakicept-pmln
Sensitive
:
B
nogapendekin alfa inbakicept-pmln
Sensitive: B - Late Trials
nogapendekin alfa inbakicept-pmln
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login